LivaNova appoints Susan Podlogar to board and compensation committee

LivaNova PLC

Appointed October 8, 2024 to Board and Compensation and Human Capital Management Committee.
Podlogar, 61, served as MetLife EVP/CHRO until June 2024 and 16 years at Johnson & Johnson.
Receives $60,000 annual retainer, $8,000 committee fee, and $180,000 RSU grant prorated for 2024.
No material transactions or arrangements between Podlogar and LivaNova since Jan 1, 2023.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Susan Podlogar

Director

LIVN · LivaNova PLC

Effective: 2024-10-08
Filed: October 8, 2024, 7:59 PM ET

On October 8, 2024, the Board of Directors (the “Board”) of LivaNova PLC (the “Company”) appointed Susan Podlogar to the Board and as a member of the Compensation and Human Capital Management Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Susan Podlogar was appointed as Director at LivaNova PLC.

Action: appointed
Role: Director

Exact text from the filing

On October 8, 2024, the Board of Directors (the “Board”) of LivaNova PLC (the “Company”) appointed Susan Podlogar to the Board and as a member of the Compensation and Human Capital Management Committee of the Board.

View on SEC.gov

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-24-000125

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.